Udg Healthcare (OTCMKTS:UDHCF) – Jefferies Group lowered their FY2020 earnings estimates for shares of Udg Healthcare in a note issued to investors on Monday. Jefferies Group analyst J. Vane-Tempest now anticipates that the company will post earnings per share of $0.50 for the year, down from their previous estimate of $0.51.

Separately, Zacks Investment Research downgraded shares of Udg Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, August 18th.

Udg Healthcare (UDHCF) remained flat at $$12.65 during mid-day trading on Wednesday. Udg Healthcare has a 52 week low of $8.01 and a 52 week high of $12.65.

WARNING: “FY2020 EPS Estimates for Udg Healthcare (UDHCF) Reduced by Analyst” was reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/12/06/fy2020-eps-estimates-for-udg-healthcare-udhcf-reduced-by-analyst.html.

Udg Healthcare Company Profile

UDG Healthcare plc, together with its subsidiaries, provides clinical, commercial, communication, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and continental Europe. It operates through three segments: Ashfield, Sharp, and Aquilant.

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.